LEXINGTON, Ky., July 12, 2021 – Thynk Health, the Complete Lung Cancer Screening Solution, announced and welcomed Kim Parham as VP of Strategic Partnerships and Clinical Liaison as the company enters into a new wave of growth and business development. Kim began her professional career upon getting her degree at Vanderbilt University and brings with her […]
May 10, 2021 – Lexington, KY: Thynk Health is transforming cancer screening and incidental findings management with the state-of-the-art Enterprise Incidental Findings Tracker. In the United States, approximately 1.9 million new cancer cases are expected to be diagnosed in 2021 alone. While healthcare systems offer some of the most advanced treatments for cancer in the
Download White Paper PDF Abstract In 2019, 142,670 Americans died of lung cancer— more than colorectal, breast and prostate cancer combined. Lung cancer remains the leading cause of cancer death. However, according to the American Lung Association (ALA), only 5.7 percent of the estimated 15 million eligible Americans at risk of developing lung cancer will
Build and Grow Your Lung Cancer Screening Management Program Read More »
LCS Program – ROI & Total Capture of Eligible Patients Manual LCS Solution vs Thynk Health’s Automated LCS Solution DOWNLOAD WHITE PAPER PDF The State of Lung Cancer Research Currently, 1 in 15 people in the U.S. can expect to receive a lung cancer diagnosis. Lung cancer kills almost twice as many women as breast
LCS Program – ROI and Total Capture of Eligible Patients Read More »
Lung Cancer Screenings Could Double, Is Your Program Prepared? The United State Preventive Services Task Force (USPSTF) issued new guidance on lung cancer screening that could make a significant impact, possibly even saving an additional 60,000 people annually. Lung cancer continues to be the second most common cancer and the leading cause of cancer death
Lung Cancer Screenings Could Double, Is Your Program Prepared? Read More »
DOWNLOAD PDF Incidental findings: Results that arise that are outside the original purpose for which the test or procedure was conducted. Overview As imaging technology continues to advance, anomalies are increasingly more detectable, making incidental findings more commonplace. Recent systematic reviews (1) noted the mention of these findings in radiology reports is as high as
Thynk Health and InferVision Partner to Fight Lung Cancer with Advanced AI and Deep Learning Technologies [02/10/2021], Lexington, KY: Thynk Health and Infervision, pioneers in the healthcare artificial intelligence space, have announced a partnership between their platforms to fight lung cancer with the world’s most advanced technologies. By combining AI-driven data and analytics abstracted from EHRs
DOWNLOAD PDF As one of 100 great hospitals in the U.S. according to Becker’s Healthcare, MercyOne Des Moines Medical Center is among the nation’s high-performing hospitals, recognized for excellence in clinical care, patient outcomes and staff and physician satisfaction. One of central Iowa’s largest multi-specialty clinic systems, MercyOne is made up of more than 50
Case Study: MercyOne Des Moines Lung Cancer Screening Read More »
MercyOne Des Moines Increases New Patient Lung Cancer Screenings by 76.2% in the First Year [09/24/2020], Lexington, KY: Lung Cancer accounts for 25 percent of cancer-related deaths in the U.S. and causes more deaths than the next three cancers combined. Yet, lung cancer screening rates remain some of the lowest. Empowered by Thynk Health’s complete
Thynk Health Solution Empowers MercyOne Des Moines to Grow Lung Screening Program Read More »
Uniquely suited for the mobile environment, Thynk Health offers the ability to manage and track complex medical care to increase accessibility of screenings [07/27/2020], Lexington, KY: CHI Memorial Chattanooga innovates with Thynk Health’s state-of-the-art screening technology and a mobile screening bus to bring lung screening to rural areas with high rates of at-risk patients and
Mobile Lung Screening Read More »
